JNJ
-
Spine
Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants
The Acquired Technology Will Complement Johnson & Johnson Medical Devices Companies’ Advanced Portfolio of Interbody Implants For Both Minimally Invasive…
Read More » -
Financial
Another Sign of Medical Device Commoditization?
Written By: Chris Provines Rumors circulated this week that Cardinal Healthcare is in talks to buy Cordis, a manufacturer of medical…
Read More » -
Financial
J&J Said to Be in Talks on Sale of Cordis, With Cardinal Leading
by Cynthia Koons and Ed Hammond (Bloomberg) — Johnson & Johnson, the world’s biggest maker of health-care products, is in talks to sell…
Read More » -
Financial
Medical devices weigh on J&J; focuses on innovation, hospital bundling to improve
By Stacy Lawrence Johnson & Johnson ($JNJ) is working to make its medical device business grow as fast as the…
Read More » -
Financial
J&J’s medical device sales take a hit
January 20, 2015 by Brad Perriello Sales for Johnson & Johnson’s medical device business slide as the strong dollar takes…
Read More » -
Recon
Johnson & Johnson Will Make Clinical Data Available to Outside Researchers
By KATIE THOMAS The health care giant Johnson & Johnson has agreed to make detailed clinical trial data on its…
Read More » -
Spine
FDA approves J&J spinal device for rare pediatric syndrome
December 8, 2014 by Val Kennedy Johnson & Johnson’s DePuy Synthes Spine unit wins an FDA nod for a titanium…
Read More » -
Financial
J&J demands $7.2 billion from Boston Scientific as trial begins
BY JOSEPH AX (Reuters) – Boston Scientific Corp should pay Johnson & Johnson$7.23 billion in damages and interest for breach…
Read More » -
Extremities
JNJ continues to pay hefty integration charges on Synthes deal
October 16, 2014 by Brian Johnson More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson…
Read More » -
Financial
Johnson & Johnson Reports 2014 Third-Quarter Results:
NEW BRUNSWICK, N.J., Oct. 14, 2014 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $18.5 billion for the…
Read More » -
Financial
What will medtech look like in 2020? — J&J may not be on top: 10 key trends
Written by Laura Dyrda The medtech market is expected to grow over the next six year as several external factors…
Read More » -
Robotics
DEPUY SYNTHES ANNOUNCES AGREEMENT WITH BLUE BELT TECHNOLOGIES, INC. AGREEMENT ENABLES ACCESS TO THE SIGMA® HP PARTIAL KNEE ON THE NAVIO™ SURGICAL SYSTEM
WARSAW, IN – (September 17, 2014) DePuy Synthes, the world’s largest provider of orthopaedic and neurological solutions, announced today a…
Read More » -
Financial
Indian media accuse Medtronic, Abbott, J&J of price-hikes, bribery
September 16, 2014 by Arezu Sarvestani Media reports in India claim that some of medtech’s biggest companies are looking the…
Read More » -
Uncategorized
Bellwether trial kicks off for DePuy’s Pinnacle hip implant
The 1st bellwether trial gets under way in product liability lawsuits filed over Johnson & Johnson subsidiary DePuy’s Pinnacle line…
Read More » -
Uncategorized
Johnson and Johnson Heads to Jury Trial over Hip Implants
by Nancy Crotti Jury selection was set to begin today in the first of about 6,000 claims against Johnson & Johnson’s DePuy subsidiary…
Read More »